United States Federal Circuit
UCB, Inc. v. Accord Healthcare, Inc., 16-2610
Affirming the district court's conclusion that asserted claims relating to lacosamide, a class of functionalized amino acid compounds, are not invalid and that the court applied the correct legal standards in its obviousness, double patenting, and anticipation analyses.
Appellate Information
- Published 2018/05/23
Judges
- STOLL
Court
- United States Federal Circuit